Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Morice

Showing results (201-210 of 284) with videos related to

Pageof 29
Sort By:
Gynecologic Oncology Reports|October 4, 2017
Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative typesSebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Archives of Gynecology and Obstetrics|June 5, 2024
Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemicSara Nasser, Christina Fotopoulou, Murat Gültekin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 21, 2010
Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 casesThibault de La Motte Rouge, Patricia Pautier, Annie Rey, et al.
CA: a Cancer Journal for Clinicians|July 31, 2019
Brachytherapy: An overview for cliniciansCyrus Chargari, Eric Deutsch, Pierre Blanchard, et al.
Gynecologic Oncology Reports|October 13, 2017
Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?Sebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Journal of Minimally Invasive Gynecology|August 6, 2013
Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancerMichael Frumovitz, Denis Querleu, Antonio Gil-Moreno, et al.
Journal of Clinical Medicine|May 16, 2020
Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External RadiotherapyKatarzyna Holub, Fabio Busato, Sebastien Gouy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 25, 2019
Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancerMaximilian P Schmid, Lars Fokdal, Henrike Westerveld, et al.
Oncotarget|September 30, 2015
Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survivalNikiforos-Ioannis Kapetanakis, Catherine Uzan, Anne-Sophie Jimenez-Pailhes, et al.
Bulletin Du Cancer|March 2, 2023
[Current post-surgical treatment strategies in first-line ovarian cancer]Kaïssa Ouali, Judith Michels, Felix Blanc-Durand, et al.
Pageof 29

Showing results (201-210 of 284) with videos related to

Sort By:
Pageof 29
Gynecologic Oncology Reports|October 4, 2017
Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative typesSebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Archives of Gynecology and Obstetrics|June 5, 2024
Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemicSara Nasser, Christina Fotopoulou, Murat Gültekin, et al.
European Journal of Cancer (Oxford, England : 1990)|September 21, 2010
Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 casesThibault de La Motte Rouge, Patricia Pautier, Annie Rey, et al.
CA: a Cancer Journal for Clinicians|July 31, 2019
Brachytherapy: An overview for cliniciansCyrus Chargari, Eric Deutsch, Pierre Blanchard, et al.
Gynecologic Oncology Reports|October 13, 2017
Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?Sebastien Gouy, Marine Saidani, Amandine Maulard, et al.
Journal of Minimally Invasive Gynecology|August 6, 2013
Lymphadenectomy in locally advanced cervical cancer study (LiLACS): Phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancerMichael Frumovitz, Denis Querleu, Antonio Gil-Moreno, et al.
Journal of Clinical Medicine|May 16, 2020
Analysis of Systemic Inflammatory Factors and Survival Outcomes in Endometrial Cancer Patients Staged I-III FIGO and Treated with Postoperative External RadiotherapyKatarzyna Holub, Fabio Busato, Sebastien Gouy, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 25, 2019
Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancerMaximilian P Schmid, Lars Fokdal, Henrike Westerveld, et al.
Oncotarget|September 30, 2015
Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survivalNikiforos-Ioannis Kapetanakis, Catherine Uzan, Anne-Sophie Jimenez-Pailhes, et al.
Bulletin Du Cancer|March 2, 2023
[Current post-surgical treatment strategies in first-line ovarian cancer]Kaïssa Ouali, Judith Michels, Felix Blanc-Durand, et al.
Pageof 29